682 related articles for article (PubMed ID: 33237291)
1. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
[TBL] [Abstract][Full Text] [Related]
3. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
4. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
[TBL] [Abstract][Full Text] [Related]
5. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
[TBL] [Abstract][Full Text] [Related]
6. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
[TBL] [Abstract][Full Text] [Related]
7. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR; Jones KM
Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
[TBL] [Abstract][Full Text] [Related]
8. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study.
Robustelli Test E; Sena P; Locatelli AG; Carugno A; di Mercurio M; Moggio E; Gambini DM; Arosio MEG; Callegaro A; Morotti D; Gianatti A; Vezzoli P
Pediatr Dermatol; 2022 Jan; 39(1):77-83. PubMed ID: 34989043
[TBL] [Abstract][Full Text] [Related]
9. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
[TBL] [Abstract][Full Text] [Related]
10. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
Kashetsky N; Mukovozov IM; Bergman J
J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
[TBL] [Abstract][Full Text] [Related]
11. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
[TBL] [Abstract][Full Text] [Related]
13. Pediatric COVID toes and fingers.
Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
[TBL] [Abstract][Full Text] [Related]
14. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review.
Starkey SY; Kashetsky N; Lam JM; Dutz J; Mukovozov IM
J Cutan Med Surg; 2023; 27(3):277-284. PubMed ID: 37340564
[TBL] [Abstract][Full Text] [Related]
15. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
[TBL] [Abstract][Full Text] [Related]
17. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.
Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S
Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
[TBL] [Abstract][Full Text] [Related]
20. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
Cappel MA; Cappel JA; Wetter DA
Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
